Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Shanghai Electric Accelerates Industrial Digitalization with Upgrades to SEunicloud
2020-06-01 11:42
Winners of iQIYI Hit Variety Show "Youth With You Season 2" Make Their Debut as Girl Group
2020-06-01 10:12
Supermicro CEO Computex Keynote - 5G Infrastructure Innovation
2020-06-01 10:00
Magellan Financial Group Limited Adopts BasisCode Compliance System in Australia
2020-06-01 09:00
Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal
2020-06-01 08:45
Innovent Biologics Announced the Results of the Phase 1b Clinical Study of TYVYT® (Sintilimab Injection) in Combination with IBI305 (Bevacizumab Biosimilar) in the Treatment of Advanced Hepatocellular Carcinoma
2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
2020-06-01 07:30
Innovent Biologics and Lilly Jointly Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Patients with Relapsed/Refractory Classic Hodgkin's Lymphoma
2020-06-01 07:30
Innovent Biologics Announced the Long-Term Follow-Up Results of TYVYT® (Sintilimab Injection) in the Treatment of Relapsed or Refractory Extranodal NK/T-Cell Lymphoma (Nasal Type)
2020-06-01 07:30
Autoliv Provides Market and Business Update, Accelerates Mitigating Measures and Enters Loan Facility With Swedish Export Credit Corporation
2020-05-29 14:57
Ping An Voyager Fund Leads Investment in PlusDental to Enhance Modern Dentistry in Europe
2020-05-29 09:48
Zai Lab Announces Positive Topline Results from the NORA Phase 3 Study of ZEJULA® as Maintenance Therapy for Chinese Patients with Platinum-sensitive, Recurrent Ovarian Cancer
2020-05-29 07:05
Shinshu University and Toshiba Develop Tumor-Tropic Liposome Technology that Carries Therapeutic Genes into Cancer Cells
2020-05-28 23:00
Hang Lung Publishes Sustainability Reports 2019
2020-05-28 19:52
Abridge Initiates Coverage on V1 Group with a "Buy" Rating and HK$0.29 Price Target
2020-05-28 18:34
Mayne Pharma Executes 20 Year License and Supply Agreement for Novel Oral Contraceptive in Australia
2020-05-28 17:23
Merck and Twitch Join Forces on World Multiple Sclerosis Day to Connect People Living With MS
2020-05-28 16:00
CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna's Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2
2020-05-28 13:30
Ping An's Object Detection Model Breaks Record in International Computer Vision Competition
2020-05-28 13:30
Huami Establishes a Brain-computer Interface Joint Lab with Top Chinese University
2020-05-28 12:06
1
746
747
748
749
750
1144